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Abstract
Background: Cancer and normal stem cells (SCs) share proliferative properties of self-renewal and expression of key
transcription factors (TFs). Despite similar TF identities, the functional role of specific TFs responsible for retaining SC state
has yet to be examined in cancer.
Methodology/Principal Findings: Here, we compare the role of Oct4 and Nanog, two-core pluripotent TFs, in transformed
(t-hPSCs), and normal human pluripotent stem cells (hPSCs). Unlike normal SCs, self-renewal and survival of t-hPSCs were
found to be independent of Oct4. In contrast, t-hPSCs exhibit hypersensitivity to reduction in Nanog and demonstrate
complete loss of self-renewal coupled with apoptosis. Dual and sequential knockdown of Oct4 and Nanog revealed that
sensitivity of t-hPSCs to Nanog was Oct4 dependent.
Conclusions/Significance: Our study indicates a bifurcation for the role of two-core SC and cancer related TFs in self-
renewal and survival processes. We suggest that the divergent roles of these TFs establish a paradigm to develop novel
therapeutics towards selective destruction of aggressive tumors harboring cancer stem cells (CSCs) with similar molecular
signatures.
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Introduction
Cancer cells share a variety of properties with normal SCs
including self-renewal capacity, but lack the ability to differentiate
and undergo apoptosis in a similar fashion to normal SCs. Cell
populations have been identified in a variety of human cancers
that possess self-renewal capacity, but are also capable of initiating
tumor heterogeneity in xenograft models [1,2,3,4,5,6]. These
properties, along with phenotypic resemblance to normal SCs,
define the term Cancer Stem Cell (CSC) [7,8] and perpetuate the
notion that CSCs may capitalize on molecular machinery
controlling normal SC function for maintaining oncogenic
properties. For example, Bmi-1, a polycomb group (PcG) gene,
was shown to be essential for both normal and leukemic mouse SC
proliferation [9]. Aside from this work, little is known about the
functional relevance of genetic determinants to CSCs versus their
normal SC equivalents.
Molecular control of self-renewal is well established in the
embryonic stem cell (ESC) system and has been found to be
governed by a core set of TFs that maintain the undifferentiated
ground state [10]. These factors that include Octamer4 (Oct4)
[11,12] and Nanog [12,13,14] have recently been associated with
highly aggressive adult tumors [15,16,17,18,19,20]. These obser-
vations suggest that factors controlling robust self-renewal unique
to ESCs may be important for aggressive somatic tumor growth
[21]. To this point, overexpression of Oct4 is sufficient to induce
dysplastic growth in adult mouse epithelium [22] and enhance the
malignant potential of ESC-derived germ cell tumors [19].
Similarly, Nanog expression has also been detected in a variety
of human neoplasms [23,24,25,26,27,28,29]. Downregulation of
Nanog has recently been shown to inhibit prostate, breast and
colon tumor development both in vitro and in vivo [15]. However,
the functional and mechanistic roles of Oct4 and Nanog in CSCs vs.
normal SCs are unknown.
hPSCs with features of neoplastic progression including
aberrant self-renewal and resistance to differentiation amounting
to enhanced tumorigenic potential have recently been charac-
terized [30]. To determine the role of core pluripotent TFs in
human SC transformation, we directly compared the effect of
Oct4 and Nanog downregulation on self-renewal of normal vs.
transformed hPSCs. t-hPSCs, unlike their normal counterparts,
are independent of Oct4 for self-renewal, pluripotency and
survival. Both cell types require Nanog for SC state maintenance,
but t-hPSCs exhibit an unprecedented dependency on Nanog for
self-renewal and cell survival. Our study establishes a paradigm
by which functional divergence of pluripotent TFs from the
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fore be used to develop therapies targeting somatic CSCs in
aggressive tumors.
Results
Downregulation of Oct4 Does Not Alter Self-Renewal or
Survival of t-hPSCs
To determine the functional relevance of Oct4 in normal and
transformed hSCs, we stably knocked down Oct4 levels in both
normal hPSCs and t-hPSCs using shRNA. Quantification of Oct4
downregulation by flow cytometry demonstrated effective knock-
down in both cell types (Figure S1A–H). This was determined by
frequency of Oct4+ cells (Figure S1A–C, E–G) and the number of
Oct4 molecules/cell measured by mean fluorescent intensity
(Figure S1D and H).
Consistent with previous reports [31,32] hPSC colonies
differentiated 7 days following Oct4 depletion (Figure S1I–L).
However, hPSC cultures are morphologically, phenotypically, and
functionally heterogeneous, and are re-established by rare colony-
initiating cells (CICs) enriched in the SSEA3+ fraction [33]. To
dissect the role of Oct4 in this clonogenic subpopulation, we
isolated normal hPSCs based on green fluorescent protein (GFP)
in combination with the undifferentiated hSC marker SSEA3 and
quantitatively compared subsequent colony growth (Figure S2).
Oct4 downregulation resulted in visible differentiation of hPSC
colonies (Figure 1A–D).
To investigate the molecular mechanisms associated with Oct4
depletion in hPSCs, we compared changes in transcript levels of
Oct4, Nanog, SRY (sex determining region Y)-box 2 (Sox2), V-
myc myelocytomatosis viral oncogene homolog (avian) (c-Myc),
dipeptidyl-peptidase 4a (Dpp4a) and T-box 3 (Tbx3), all
implicated in pluripotent stem cell maintenance (Table S2)
[12,34]. As expected, lentiviral shRNA transduction of Oct4
significantly reduced Oct4 but also downregulated Nanog
transcripts in SSEA3+ hPSCs (Figure 1E). However, Sox2, c-
Myc and Tbx3 levels showed slight, non-significant increases
following Oct4 dysregulation (Figure 1E) while Dpp4a levels were
minimally decreased (Figure 1E). Taken together, our results
confirm the previously established role of Oct4 in differentially
regulating gene expression in normal hPSCs, and the central
importance of these factors in maintaining the pluripotent state
[12,31,34,35,36].
In addition to the molecular changes seen following Oct4
knockdown, we dissected the biological effects on the self-renewing
hPSC SSEA3+ fraction. Oct4 downregulation reduced the total
number of clonogenic self-renewing cells (CICs) by 64% compared
with cells transduced with the eGFP control vector (Figure 1F). In
addition, Oct4 downregulation significantly decreased the fre-
quency of undifferentiated SSEA3
+ cells and increased the
frequency of the neural precursor marker, A2B5, compared with
control eGFP cells (Figure 1G–H). Oct4 knockdown also induced
cell death as demonstrated by AnnexinV
+ staining (Figure 1I).
These results show that Oct4 regulates a differentiation response in
the self-renewing fraction of normal hPSCs and is therefore
required for maintenance and survival of the hPSC undifferenti-
ated state.
Unlike normal hPSCs, t-hPSCs are less morphologically and
phenotypically heterogeneous demonstrated by ubiquitous expres-
sion of SSEA3 throughout the culture, and do not require the
fibroblast-like cell supportive niche [30]. To evaluate the
functional role of Oct4 in t-hPSCs, we stably knocked down
Oct4 by shRNA and then isolated fractions based on green
fluorescent protein (GFP) (Figure S2). Surprisingly, both t-hPSC
bulk cultures (Figure S1M–P) and GFP+ fractions (Figure 1J–M)
appeared completely unaffected by Oct4 dysregulation. Undiffer-
entiated colonies were phenotypically similar to both the control
and parental t-hPSCs (Figure 1J–M).
Comparable to normal hPSCs, Oct4 reduction in t-hPSCs
resulted in a significant and predictable reduction in Oct4 as well
as a similar decline in Nanog and a small increase in Sox2 levels
(Figure 1N). Along with a substantial increase in Tbx3 expression,
both c-Myc and Dpp4a were significantly reduced in Oct4 t-
hPSCs. (Fig. 1N). Differential regulation of c-Myc, Dpp4a and
Tbx3 reveals a molecular distinction in response to Oct4 depletion
between t-hPSCs and hPSCs that may be, at least in part,
responsible for the lack of response of t-hPSCs to Oct4
dysregulation.
Although there were no discernible changes in t-hPSC colonies
following Oct4 knockdown, we further assessed the functional
relevance of Oct4 to t-hPSC clonogenic self-renewal, differentia-
tion and survival. Unlike normal hPSCs, downregulation of Oct4
had no effect on colony formation (Figure 1O) or the frequencies
of SSEA3
+, A2B5
+, and AnnexinV
+ cells over multiple passages
(Figure 1P–R). The inability to alter self-renewal in t-hPSCs
persisted even four months after Oct4 depletion (Figure S1Q–T).
These data demonstrate that Oct4 is dispensable for the self-
renewal and survival of t-hPSCs, but is critical to normal hPSC
maintenance. Despite the established key role of Oct4 in sustaining
pluripotency, our results provide direct evidence for the
functional divergence of Oct4 from the pluripotent state following
transformation.
Oct4 Is Not Required for Pluripotency and Tumorigenicity
of t-hPSCs
hPSC pluripotency is determined in vivo by the presence of all 3
germ layers in teratomas formed in human-mouse xenografts.
Teratomas are formed from a rare subset of cells present at a
frequency of 1:17500 cells in normal hPSCs [30]. In contrast, we
have recently shown that t-hPSCs are highly enriched for
teratoma-initiating cells (TICs) with a frequency of 1:800 and
give rise to teratomas containing clusters of Oct4 positive cells
[30]. Oct4 expression has been associated with more aggressive
tumors and is suggested to be a malignant teratocarcinoma marker
in vivo [19,37,38]. To determine whether Oct4 is related to the
higher TIC frequency and capacity of t-hPSCs, we injected t-
hPSCs depleted in Oct4 at different cell doses into NOD-SCID
mice. All mice (9/9 mice), regardless of limiting dose, developed
teratomas (Figure 2A; Table S1). Teratomas generated from both
Oct4 depleted and control t-hPSCs consisted of tissues represent-
ing all three germ layers (Figure 2B–G; Table S1). Additionally, in
7 of 8 Oct-4 depleted teratomas, Oct4 staining was absent
demonstrating sustained Oct4 knockdown in these tumors (data
not shown). Furthermore, these teratomas were similar in size to
controls suggesting that Oct4 does not affect t-hPSC proliferation
or TIC capacity in vivo (Figure 2A; Table S1). These results
demonstrate that t-hPSCs with depleted Oct4 retain pluripotency
and TIC capacity and indicate that the enhanced tumorigenesis of
t-hPSCs [30] is not dependent on Oct4. These functional results
question previous notions that retention of Oct4 alone can be used
as a functional indicator of hSC transformation [19,37,38].
t-hPSCs Are Dependent on Nanog for Survival and Self-
Renewal
In addition to Oct4, Nanog has also been established as a core
pluripotency factor [13,14]. However, the role of Nanog in SC
transformation is unknown. To determine the functional relevance
Oct4/Nanog in Transformation
PLoS ONE | www.plosone.org 2 November 2009 | Volume 4 | Issue 11 | e8065Figure 1. Oct4 knockdown does not affect self-renewal, differentiation and survival of t-hPSCs. (A–D) Representative images of colonies
generated from GFP
+SSEA3
+ cells 11 days post-sort from control (A and B) and Oct4 knockdown (C and D) normal hPSCs. Scale bar=100 mm, n=3.
Note the compact appearance and well-defined border of the typical hPSC colony in A and B. In contrast, the cells within the more differentiated
colony in C and D exhibit a higher cytoplasm to nuclear ratio, are less compact, and do not form a well-defined colony border. (E) qPCR of fold
changes in Oct4, Nanog, Sox2, c-Myc, Dpp4a, and Tbx3 transcripts in Oct4 knockdown hPSCs relative to hPSC
eGFP controls. Bar graphs represent
mean values 6 SEM, n=3, ***, p,0.001. (F) Clonogenic self-renewal of SSEA3
+ cells isolated from control (39.364.3610
4) and Oct4 knockdown
(1462.3610
4) hPSCs. 1610
4 GFP
+SSEA3
+ cells were isolated from hPSCs 2 days after transduction with eGFP control and Oct4 knockdown lentiviral
vectors and seeded on ihdFs. GFP
+ colonies were scored 9 days after seeding. Bar graphs represent mean values 6 SEM, n=3. **, p,0.01. (G–I)
Frequency of GFP
+SSEA3
+ (G) GFP+A2B5+ (H) and GFP+AnnexinV+ (I) cells for three passages of culture derived from sorted GFP
+SSEA3
+ fractions of
control and Oct4 knockdown hPSCs. N=3 for each. Line graphs represent mean values 6 SEM. * p,0.05, ** p,0.01. (J–M) Representative images of
colonies generated from sorted GFP
+ cells 6 days post-sort from control (J–K) and Oct4 knockdown (L–M) t-hPSCs. Scale bar=100 mm, n=5. Arrow
denotes the typical appearance of tightly packed undifferentiated colonies. (N) qPCR of fold changes in Oct4, Nanog, Sox2, c-Myc, Dpp4a, and Tbx3
transcripts in Oct4 knockdown t-hPSCs relative to t-hPSC
eGFP control cells. Bar graphs represent mean values 6 SEM, n=3, **, p,0.01, ***, p,0.001.
(O) Clonogencity of GFP
+ cells isolated from control and Oct4 knockdown t-hPSCs. 1610
4 GFP
+ cells were sorted from t-hPSCs 4 days after
transduction with eGFP control and Oct4 knockdown lentiviral vectors and seeded on ihdFs. GFP
+ Colonies were scored 6 days after. Bar graphs
represent mean values 6 SEM, n=3. (P–R) Frequency of GFP
+SSEA3
+ (P) GFP+A2B5+ (Q) and GFP+AnnexinV+ (R) cells for three passages of culture
derived from sorted GFP
+ fractions of control and Oct4 knockdown t-hPSCs. P, n=9. Q, n=5, R, n=3. Line graphs represent mean values 6 SEM.
doi:10.1371/journal.pone.0008065.g001
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Nanog using shRNA in both hPSCs and t-hPSCs (Figure S1U).
Consistent with previous reports [31], Nanog depletion resulted in
the differentiation of colonies in normal hPSC cultures demon-
strating that this TF is required for normal pluripotent SC cell
maintenance (Figure 3A–B). Since normal hPSCs underwent
differentiation, we then isolated transduced GFP+ hPSCs
expressing the primitive marker SSEA3 to investigate the specific
effect of Nanog depletion on the self-renewing clonogenic fraction.
Nanog and Oct4 co-occupy target genes and form specialized
autoregulatory and feedforward loops to establish molecular
control of ESC pluripotency [12,39]. To evaluate the molecular
mechanisms responsible for the functional changes in clonogenic
hPSCs following Nanog knockdown, we looked at transcript levels
of genes associated with hPSC pluripotency. While shRNA-based
Nanog depletion decreased Dpp4a expression, both Oct4 and c-
Myc levels remained unchanged in normal hPSCs (Figure 3C). In
contrast, Tbx3 transcript was significantly upregulated along with
an increase in Sox2 levels (Figure 3C). The similar gene expression
patterns following both Oct4 and Nanog downregulation in
hPSCs confirm previous studies demonstrating that these TFs
share several targets [12].
To characterize the relevance of Nanog dysregulation to hPSC
function, we examined the effect of Nanog reduction on hPSC
clonogenic self-renewal, differentiation and survival. Similar to
Oct4, Nanog downregulation also significantly decreased the
number of colonies generated from the SSEA3+ subset as
compared to controls (Figure 3D). This indicates a critical role
for Nanog in the clonogenic self-renewal of normal hPSCs. This
reduction in self-renewal potential was consistent with the loss in
SSEA3 over passage and was also accompanied by an increase in
the expression of the neural marker A2B5 [30] demonstrating a
role for Nanog in preventing differentiation (Figure 3E–F).
Additionally, Nanog knockdown induced apoptosis represented
by an increased frequency of Annexin V
+ cells (Figure 3G).
Together, these results show that Nanog is critical in maintaining
the undifferentiated state of normal hPSCs while repressing both
neural differentiation and apoptosis.
Transformed-hPSCs expressed only slightly higher levels of
Nanog than normal hPSCs. (Figure S1 V). Given the lack of effect
of Oct4 depletion on transformed cells, we sought to investigate
whether Nanog regulates t-hPSC function. Nanog knockdown
induced differentiation and compromised viability in t-hPSCs bulk
compared to eGFP controls (Figure 3H–I). To evaluate the
molecular mechanisms associated with these biological changes,
we isolated GFP
+ cells from Nanog-depleted t-hPSCs and
examined transcript levels of Oct4, Nanog, Sox2, c-Myc, Dpp4a
and Tbx3 compared with cells transduced with the control eGFP
vector. Relative to normal hPSCs, Nanog knockdown in t-hPSCs
resulted in similar patterns of Nanog, Oct4, Sox2, and Dpp4a
transcript regulation (Figure 3J). However, significant decreases in
both c-Myc and Tbx3 (Figure 3J) demonstrate that Nanog
differentially regulates transcriptional networks in t-hPSCs com-
pared with normal cells.
To understand the potential biological effects of Nanog
depletion on the self-renewing fraction, transduced t-hPSCs were
selected and cultured to evaluate effects on self-renewal,
differentiation and apoptosis. Surprisingly, Nanog downregulation
completely abolished colony formation capacity (Figure 3K)
revealing an obligatory role for Nanog in the clonogenic self-
renewal unique to t-hPSCs vs. normal hPSCs. Since colonies could
not be recovered following Nanog depletion in t-hPSCs, we
measured the effect of Nanog downregulation on t-hPSC
differentiation using GFP+ cells from transduced bulk culture.
SSEA3 levels were significantly reduced after 3 passages, however,
there was no change in frequency of cells expressing A2B5
Figure 2. Downregulation of Oct4 has no effect on t-hPSC pluripotency or tumor-initiating cell capacity. (A) Summary of teratoma
formation from control and Oct4 knockdown t-hPSCs at serial injected cell doses. Cell doses of 7.5610
3, 2.4610
4, and 6.6610
4 t-hPSCs and 1.5610
4,
3.3610
4 and 6.6610
4 Oct4 knockdown t-hPSCs were injected into the testis capsules of NOD/SCID mice. Mice were sacrificed 6 weeks after injection.
Teratoma size was measured and plotted relative to injected cell doses. N=7. (B–G) Representative histology of teratomas formed in NOD/SCID mice
testes 6 weeks following injection of control t-hPSCs (B–D, upper panel) or Oct4 knockdown t-hPSCs (E–G, bottom panel). Tissues representing all
three embryonic germ layers including ectoderm (neural rosettes, B and E, left panels), mesoderm (cartilage, C and F, middle panels), and endoderm
(columnar epithelium, D and G, right panels) are shown. Scale bar=50 mm.
doi:10.1371/journal.pone.0008065.g002
Oct4/Nanog in Transformation
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Nanog does not regulate t-hPSC neural differentiation. t-hPSCs
also underwent a significant apoptotic induction shown by an
increased frequency of Annexin V
+ cells (Figure 3N). Together,
these results demonstrate a potent and distinct hypersensitivity of t-
hPSCs to Nanog.
Figure 3. t-hPSCs exhibit a heightened self-renewal and survival response following Nanog dysregulation. (A–B) Representative
images of normal hPSC bulk culture one week after transduction with a lentivector carrying an shRNA sequence targeting Nanog. Scale bar=100 mm,
n=5. A: Phase contrast. B: GFP. Note the less compact colony morphology and the differentiated interior. Arrow denotes differentiated cells in the
hPSC colony centre following Nanog knockdown. (C) qPCR demonstrating fold changes in Oct4, Nanog, Sox2, c-Myc, Dpp4a, and Tbx3 transcripts in
GFP
+SSEA3
+ cells isolated from Nanog knockdown hPSCs relative to the control, respectively. Bar graphs represent mean values 6 SEM, n=3. **,
p,0.01, ***, p,0.001. (D) Clonogenic self-renewal of SSEA3
+ cells isolated from control and Nanog knockdown hPSCs. 1610
4 GFP
+SSEA3
+ cells were
isolated from hPSCs 2 days after transduction with eGFP control and Nanog knockdown lentiviral vectors and seeded on ihdFs. GFP
+ colonies were
scored 9 days after seeding. Bar graphs represent mean values 6 SEM, n=3. **, p,0.01. (E–G) Frequency of GFP
+SSEA3
+ (E) GFP+A2B5+ (F) and
GFP+AnnexinV+ (G) cells for three passages of culture derived from sorted GFP
+SSEA3
+ fractions of control and Nanog knockdown hPSCs. Lines
represent mean values 6 SEM, n=3. * p,0.05, ** p,0.01. (H–I) Representative images of t-hPSC bulk culture one week after transduction with a
lentivector carrying an shRNA sequence targeting Nanog. Scale bar=100 mm, n=5. H: Phase contrast. I: GFP. Arrow denotes t-hPSCs undergoing
apoptosis following Nanog downregulation. (J) qPCR demonstrating fold changes in Oct4, Nanog, Sox2, c-Myc, Dpp4a, and Tbx3 transcript in GFP
+
cells isolated from Nanog knockdown t-hPSCs. Bar graphs represent mean values 6 SEM, n=3, *, p,0.05, **, p,0.01, ***, p,0.001. (K) Clonogenic
self-renewal of GFP
+ cells isolated from control and Nanog knockdown t-hPSCs. 1610
4 were sorted from t-hPSCs 4 days after transduction with eGFP
control and Nanog knockdown lentiviral vectors and seeded on ihdFs. GFP
+ colonies were scored 6 days after seeding. Bar graphs represent mean
values 6 SEM, n=3. **, p,0.01. (L–N) Frequency of GFP
+SSEA3
+ (L) GFP+A2B5+ (M) and GFP+AnnexinV+ (N) cells for three passages of control and
Nanog knockdown t-hPSCs. Lines represent mean values 6 SEM, n=3. * p,0.05.** p,0.01.
doi:10.1371/journal.pone.0008065.g003
Oct4/Nanog in Transformation
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Dependent
Although Nanog downregulation induced cell death in t-hPSCs
(Figure 3N), Nanog transcript downregulation following Oct4
knockdown did not induce a similar apoptotic response in t-hPSCs
(Figure 1N). This suggests that Nanog-regulated survival is Oct4
dependent. To examine the specific functional relationship of
Oct4 and Nanog in transformed hSCs, we performed both dual
and sequential knockdown of Oct4 and Nanog in t-hPSCs using
the approach depicted (Figure 4A). Consistent with our previous
results, initial Oct4 knockdown had no effect on t-hPSC
differentiation (Figure 4B–C,F–G and data not shown). Surpris-
ingly, dual Oct4 and Nanog knockdown t-hPSCs survived
compared with control t-hPSCs (Figure 4D–E, H–I). The potent
apoptotic effect seen in Nanog-knockdown only transformed cells
(Figure 3N) was completely abolished when sequential knockdown
of Oct4 and Nanog was performed (Figure 4J–K). This
demonstrates that Nanog–regulated apoptosis is dependent on
Oct4. Our results reveal a hierarchical role for Nanog and Oct4 in
t-hPSC regulation.
Discussion
The core transcription factors that regulate self-renewal,
survival and developmental potential are well established in
hPSCs [12]. This provides a unique opportunity to determine the
role of these governing factors in the normal vs. transformed SC
state in a manner that cannot be fully evaluated in other CSC
systems limited by patient sample heterogeneity and availability.
Our study defines a mechanistic distinction of Oct4 and Nanog in
transformed vs. normal hSCs. While embryonic gene expression
patterns have recently been associated with malignancy
[16,17,18], we provide evidence that Oct4 alone may have unique
functions in normal SCs, whereas transformed SCs are strongly
dependent on Nanog. Based on our results, we propose a model to
describe the functional role and relationship of Oct4 and Nanog in
transformed vs. normal SC state (Figure 4L).
Differences that separate normal vs. cancer SC molecular
circuitry are not well characterized and therefore hinder
development of novel therapeutics that specifically target CSCs.
A reduction in Oct4 and Nanog levels induces spontaneous lineage
development and loss of pluripotent self-renewal capacity in
hPSCs [11,31,32]. Unlike normal SCs, Oct4 is dispensable for self-
renewal, survival and differentiation of transformed cells
(Figure 4L). In contrast, Nanog represents a t-hPSC ‘‘achilles
heel’’, as the strong survival effect combined with the abolishment
of clonogenic self-renewal reveals a fundamental dependence on a
single TF for cellular maintenance in the transformed state. The
role for Nanog in t-hPSC survival was dependent on Oct4, as
evidenced by abolishment of the apoptotic effect following dual
knockdown. The inherent vulnerability of t-hPSCs to Nanog
suggests that functional characterization of TFs governing the
pluripotent state may reveal unique dependencies of SCs upon
entry into neoplastic, transformed states of self-renewal.
While Oct4 plays a regulatory role in t-hPSC survival, our work
also indicates that Oct4 expression is not a relevant criterion to
pathologically define transformation of hPSCs in vitroo rin vivo.
This is supported by evidence demonstrating that Oct4 is not
detected in a panel of nearly 200 solid tumors [19] and is
dispensable for the maintenance of adult mammalian somatic SCs
[40]. Prior to these functional TF studies, the overexpression of
Oct4 in cultured t-hPSCs combined with the presence of Oct4-
positive pluripotent cells in teratomas [30] would have been
misconstrued as indicators of malignant progression of hPSCs. As
such, differential expression of core TF genes does not necessarily
link SCs with cancer, thus underscoring the need for functional
validation of all potential biomarkers. Nevertheless, the association
of embryonic gene expression patterns with malignancy has
recently gained considerable momentum [16,17,18]. Combined
with our results, this implies that tumor cells acquire heightened
self-renewal capacity by hijacking TFs typically associated with
hPSCs, or that CSC populations may utilize pluripotent TFs for
tumor maintenance. Involvement of Oct4 and Nanog in either
process would allow one to capitalize on these functional
dependencies and target TFs therapeutically.
TFs are critical regulators of normal SC and cancer cell self-
renewal, survival and differentiation. While similar gene expression
signatures are suggestive of a tumor stem-cell phenotype, a more
complete understanding of the mechanisms behind these potential
biological indicators or markers is essential. Without this, treatment
strategies targeting specific TFs could have vastly different and
unexpected effects on a patient’s cancer/CSC vs. normal SC
population. Our work reveals a functional divergence of transcrip-
tional machinery from the normal SC self-renewing state versus
transformation. In light of recent studies demonstrating a role for
Oct4 and Nanog in tumor progression [15,20], this mechanistic
distinction may not be exclusive to hPSCs, but more broadly
applicable to multiple CSC types. The divergent roles of Oct and
Nanog revealed in this study establish a paradigm to develop novel
therapeutics towards selective destruction of aggressive tumors
harboring CSCs with similar molecular signatures.
Materials and Methods
Ethics Statement
All animal experiments were approved by the local authority,
the Animal Care Council and Veterinary Services of McMaster
University.
Culture of hPSCs and t-hPSCs, and Formation of hEBs
H9 and H1 hPSC lines as well as the H9-derived t-hPSC line
were cultured as previously described [30]. Briefly, all cell lines
were cultured on Matrigel (BD Biosciences) coated plates and
maintained in mouse embryonic fibroblast conditioned medium
(MEF-CM) supplemented with 8 ng/ml of human recombinant
basic fibroblast growth factor (bFGF, Invitrogen) [41]. Formation
of hEBs from t-hPSCs and hematopoietic differentiation of hEBs
were performed as previously reported [30,41].
Lentiviral shRNA Vector Subcloning
Construction of the lentiviral vector Lentilox3.7 (LL3.7)
carrying the eGFP reporter was performed as described [42]. An
oligonucleotide targeting the human Nanog gene and two
oligonucleotides targeting the human Oct4/POU5F1 gene were
designed and generated [31]. The third oligonucleotide encoding
stem-loop structures targeting the human Oct4/POU5F1 gene with
the targeting sequence AATTGCTCGAGTTCTTTCT was
designed using the Darmacon company siRNA design tool
(http://www.dharmacon.com/DesignCenter/DesignCenterPage.
aspx). These oligonucleotides were subcloned into the LL3.7
vector under the control of the U6 promoter. DsRed was
subcloned into the LL3.7 control vector to replace eGFP. Briefly,
DsRed was amplified with primers (forward-AATTCGCTA-
GCCGCCACCATGGCCTCCTCC: reverse-TCGAGGAAT-
TCCTACAGGAACAGGTGGTGGCGGC) including Nhe1
and EcoR1 as restriction sites respectively and was inserted into
LL3.7 vector by replacing eGFP sequences. The oligonucleotide
targeting the human Nanog gene was also subcloned into the
Oct4/Nanog in Transformation
PLoS ONE | www.plosone.org 6 November 2009 | Volume 4 | Issue 11 | e8065Figure 4. Survival of t-hPSCs after dual and sequential knockdown of Oct4 and Nanog. (A) Schematic showing the protocol for dual and
sequential knockdown of Oct4 and Nanog in t-hPSCs. (B–I) Representative images of control (B–E) and dual Oct4 and Nanog knockdown (F–I) t-hPSCs
2 weeks after transduction with the shOct4_GFP vector followed by control DsRed and shNanog_DsRed vectors, respectively. Scale bar=100 mm,
n=3. Images are representative of individual colonies seen throughout the entire culture. Note the significant overlay between Oct4 KD-dsRED (E)
and Oct4 KD-Nanog KD (I) demonstrating that Oct4 and Nanog are downregulated in the same cells. (J) Representative FACS results showing the
frequencies of Annexin V
+ cells within GFP
+DsRed
+ fractions of control and dual Oct4 and Nanog knockdown t-hPSCs. n=3. (K) Frequency of Annexin
V
+ cells within GFP
+DsRed
+ fractions of control and dual Oct4 and Nanog knockdown t-hPSCs. (1362.1% AnnexinV+ cells in Oct4 KD/dsRED t-hPSC
controls vs 15.969.2% Annexin V+ cells in Oct4 KD/Nanog KD-dsRED t-hPSCs. Bar graphs represent mean values 6 SEM, n=3, p.0.05. (L) While both
Oct4 and Nanog are required to sustain the normal human stem cell pluripotent state, Oct4 is dispensable for transformed human stem cell self-
renewal and survival. However, transformed human stem cells are completely dependent on Nanog for both self-renewal and survival revealing a
fundamental paradigm shift in the role of core TFs following transformation. This heightened effect of Nanog on transformed cell survival is
dependent on Oct4.
doi:10.1371/journal.pone.0008065.g004
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engineered lentiviral vectors were verified by sequencing.
Lentiviral Virus Production and hPSCs Transduction
Lentiviruses were produced in 293FT cells (ATCC) as described
[42,43]. Briefly, lentiviral vectors were co-transfected with the
third generation packaging plasmids encoding gag/pol, REV and
vesticular stomatitis virus G protein at a ratio 2:1 by lipofectamine
2000 (Invitrogen) into 293FT cells (DNA/lipofectamine=1 mg/
3ml). Viral supernatants were collected 72 hours after transfection
and concentrated by ultracentrifugation to produce stock with
titers of 4.8610
7 to 8.1610
7 infectious units per milliliter. Virus
titers were determined on Hela cells. To transduce normal hPSCs
and t-hPSCs, 1.8610
7 hPSCs and 1.5610
6 t-hPSCs on day 1 after
passage were transduced with viruses in MEF-CM supplemented
with 8 ng/ml bFGF and 8 ng/ml polybrene (Chemicon interna-
tional) for 24 hours. Multiplicities of infection (MOI) of 0.1 and 1
were used to transduce the cells with LL3.7_eGFP, LL3.7_DsRed,
LLshOct4-1_eGFP, LLshOct4-2_eGFP, LLshOct4-3_GFP,
LLshNanog_eGFP, LLshNanog-DsRed lentiviral vectors.
Isolation of hPSCs for Clonogencity Analysis
Transduced hPSCs and t-hPSCs were isolated using a FACSAria
(BD Biosciences) and re-plated for the clonal assay previously described
[33]. Briefly, hPSCs were dissociated on day 2 after lentiviral
transduction and stained with SSEA3 (Develop Studies Hybridoma
Bank, mAB clone MC-631) and secondary AlexaFluor-647-goat-anti-
mouse-IgG (Molecular Probes). 1610
4 7AAD
2GFP
+SSEA3
+ cells
were sorted with 94–98% purity and seeded on 12-well tissue culture
plates coated with irradiated hPSC-derived fibroblast-like cells (ihdFs).
9 days after seeding, the number of GFP
+ colonies was counted under
fluorescent microscope (Olympus). t-hPSCs were dissociated 4 days
after transduction and 7AAD
2GFP
+ t-hPSCs were sorted and plated
at cell doses of 1610
4,1 610
3,1 610
2 and 10 on 12-well and 96-well
tissue culture plates coated with ihdFs.On day 6,total number of GFP
+
colonies derived from t-hPSCs was counted under fluorescent
microscope. Sorted hPSCs and t-hPSCs were expanded for other
assays.
Flow Cytometry Analysis of Oct4, SSEA3, A2B5 and
Annexin V
hPSCs and t-hPSCs were treated with Collagenase IV for 7 to
10 minutes followed by cell dissociation buffer (Gibco) for 10
minutes at 37uC and filtration through a 40 mmc e l ls t r a i n e r .F o r
Oct4 staining, cells were fixed and stained with mouse anti-oct3-
MAb (Beckton Dickinson), followed by secondary staining with
either Alexa fluor 647 goat anti mouse IgG (Invitrogen) or goat F
(ab’) 2 fragment anti-mouse IgG (H+L) PE. For SSEA3 staining,
we used SSEA3 (Develop Studies Hybridoma Bank, mAb clone
MC-631) and goat F(ab’)2 fragment anti-mouse IgG (H+L) PE or
FITC (Invitrogen) or Alexa fluor 647 goat anti mouse IgG
(Invitrogen). A2B5 was detected with antibodies A2B5 (R&D
systems) and Alexa fluor 647 goat anti mouse IgM (Invitrogen).
Live cells were identified by 7-aminoactinomycin D (7-AAD)
exclusion and analyzed for surface-marker expression using
FACS Calibur (BD Biosciences). The data were analyzed by
FlowJo software (Tree Star). The apoptotic status of the cells was
assessed using the AnnexinV apoptosis detection kit (BD
Biosciences) according to the manufacturer’s guidelines.
Teratoma Formation
1.5610
4, 3.3610
4, 6.6610
4 sorted Oct4 knockdown t-hPSCs
were injected into the testis capsules of three male NOD/SCID
mice in triplicate. Cell doses of 7.5610
3, 2.4610
4, and 6.6610
4 t-
hPSCs were also injected into 6 mice as control [30]. After 6
weeks, teratomas were extracted, measured and fixed with 10%
buffered formalin followed by embedding in paraffin. Five micron-
sectioned samples were stained with Hematoxalin and Eosin
(H&E) and imaged under 2006magnification.
Quantitative Polymerase Chain Reaction (qPCR) Analysis
Total RNA from hPSCs and t-hPSCs was extracted by RNeasy
Mini Kit (Qiagen) according to the manufacturer’s instructions.
cDNA synthesis was performed with 5 mg total RNA using by first-
strand cDNA synthesis kit (Amersham Biosciences). Expression of
Oct4, Nanog, Sox2, c-Myc, Dpp4a, and Tbx3 were quantified by
quantitative PCR (Mx4000, Stratagene) using SYBR green
(Invitrogen) DNA-binding dye. Quantitative PCR reaction
conditions were as follows: Primary denaturation at 95uC for
1 min and 40 cycles of PCR consisting of 95uC for 10 s, 60uC for
1 min, and 72uC for 30 s, followed by analyzing the amplified
products using the dissociation curves. The signal intensities were
normalized against GAPDH and the 2
2DDCt equation was used to
calculate the relative gene expressions [44]. The primers used are
listed in Table S2.
Statistical Analysis
Results were presented as mean 6 SEM. Statistical significance
was determined using an unpaired Student t test and results were
considered significant or highly significant when p#0.05 or #0.01,
respectively.
Supporting Information
Figure S1 Lentivirus-based Oct4 and Nanog shRNA significantly
downregulate Oct4 and Nanog expression, respectively, in both
normal hPSCs and t-hPSCs. (A-B) Representative FACS histograms
of Oct4+ cell frequency within gated GFP
+SSEA3
+ fractions from
control(A)andOct4knockdown(B)hPSCs.(C-D)Frequency(C)and
mean fluorescence intensity (D) of Oct4+ cells within gated
GFP
+SSEA3
+ fractions from control and Oct4 knockdown hPSCs.
Error bars represent SEM, n=3. (E-F) Representative FACS
histograms of Oct4+ cell frequency within gated GFP+ fraction from
control (E) and Oct4 knockdown (F) t-hPSCs. (G-H) Frequency (G)
and mean fluorescence intensity (H) of Oct4+ cells within the gated
GFP+ fraction from control and Oct4 knockdown t-hPSCs. Error
bars represent SEM, n=5. (I-L) Representative images of bulk H1
and H9 hPSCs one week after transduction with the control lentilox
vector LL3.7 (eGFP as transduction reporter, hPSCeGFP) (I-J) or the
Oct4 knockdown lentiviral vector (K and L). Scale bar=100 mm,
n=5. I and K: Phase contrast. J and L: GFP. (M-P) Representative
images of bulk H9 t-hPSCs one week following transduction with
control (M and N) and Oct4 knockdown lentiviral vectors (O and P).
n=5. M and O: Phase contrast. N and P: GFP. Scale bar=100 mm.
(Q-T) Representative images of control (Q and R) and Oct4
knockdown (S and T) t-hPSC cultures 4 months after sorting GFP+
cells. Scale bar=100 mm. (U) qPCR of fold changes in Nanog
transcripts following stable Nanog knockdown (black bars) in both
hPSCs and t-hPSCs relative to transduction with the control eGFP
lentivirus (white bars). Bar graphs represent mean values 6 SEM,
n=3, ***, p,0.001. (V) qPCR results showing the fold change of t-
hPSC Nanog transcript relative to normal hPSCs. Bar graphs
represent mean values 6 SEM, n=3.
Found at: doi:10.1371/journal.pone.0008065.s001 (2.32 MB
PDF)
Figure S2 Schematic of GFP
+SSEA3
+ and GFP+ fractions
isolation from control and Oct4 knockdown normal hPSCs and t-
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PLoS ONE | www.plosone.org 8 November 2009 | Volume 4 | Issue 11 | e8065hPSCs respectively. Sorted cells were seeded at clonal density on
irradiated hdFs and sorting purities for each fraction are shown.
Found at: doi:10.1371/journal.pone.0008065.s002 (0.02 MB
PDF)
Table S1 Limiting dilution assay for teratoma formation from
control and Oct4 knockdown t-hPSCs.
Found at: doi:10.1371/journal.pone.0008065.s003 (0.00 MB
PDF)
Table S2 Primers used in quantitative real-time reverse
transcription-polymerase chain reaction studies.
Found at: doi:10.1371/journal.pone.0008065.s004 (0.25 MB
PDF)
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